Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Surface layer protein A (SlpA) is the primary constituent of the paracrystalline S-layer that coats the cell surface of the Gram-positive pathogen Clostridioides difficile (UniProt P0C1S0). It is synthesized as a single precursor protein that is post-translationally cleaved by the protease Cwp84 into two subunits: a highly conserved High Molecular Weight (HMW) subunit and a highly variable, immunodominant Low Molecular Weight (LMW) subunit (Péchiné et al., 2018). The SLCT-4 variant represents a specific S-layer cassette type, one of several genetically distinct forms that contribute to the diversity of C. difficile strains, such as the toxin-variant ribotype 017 (Dingle et al., 2013). SlpA plays a critical role in bacterial fitness by mediating adhesion to host intestinal epithelial cells and contributing to immune evasion by forming a protective barrier (Kirk et al., 2017). As a surface-exposed protein essential for colonization and pathogenesis, it is a major target for the development of vaccines and monoclonal antibodies aimed at preventing or treating C. difficile infections. However, the significant sequence variation between different SLCT types poses a challenge for the development of broadly effective therapeutics (Dingle et al., 2013).
Inhibition of bacterial adhesion to host intestinal cells and enhancement of opsonophagocytosis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Surface layer protein A (SlpA) (SlpA).